Resources
Is Your CRO Experienced in Clinical Trials With No Clear Pathways?
ARG has “been there and done that” when it comes to operationalizing rare disease clinical trials. Our maturity can be seen in creating deep relationships, which allow us to get things done with no preexisting roadmap.
April 5, 2021
Press Release: ARG Opens New European Offices
CHARLOTTESVILLE, Va., WARSAW, Poland, and AMSTERDAM, August 27, 2019—Atlantic Research Group (ARG), a full-service global contract research organization (CRO), has […]
August 27, 2019
Does Your CRO Understand the Ultimate Trial Goal?
ARG's primary goal is to improve and prolong the lives of the people affected by rare diseases through the clinical trials we manage. We realize our patient-centric approach by carefully cultivating relationships, fostering meaningful communication, and anticipating and addressing all of the challenges in our studies.
May 23, 2019
QA Director Nancy Boxx Weighs In On FDA Draft Guidance On Use of Natural History Studies
In March, The FDA released a draft guidance on the use of natural history studies in rare disease clinical trials. […]
April 22, 2019
QA Director Nancy Boxx Comments on New FDA Guidances in Cancer Trials
Nancy Boxx, ARG Director of Quality Assurance, has provided comments for a piece on Outsourcing-Pharma.com that addresses the new FDA […]
March 15, 2019
ACRP Interviews Technology "Evangelist" (and CTO) Hunter Walker
Hunter Walker was recently interviewed by Michael Causey of the Association of Clinical Research Professionals (ACRP) about using technology to […]
September 24, 2018